Algernon Pharmaceuticals (AGNPF) Short Interest Ratio & Short Volume $0.06 0.00 (0.00%) (As of 11/18/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Algernon Pharmaceuticals Short Interest DataAlgernon Pharmaceuticals (AGNPF) has a short interest of 4,200 shares. This marks a -49.40% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 11,769 shares to cover all short positions.Current Short Interest4,200 sharesPrevious Short Interest8,300 sharesChange Vs. Previous Month-49.40%Dollar Volume Sold Short$253.05Short Interest Ratio0.4 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume108 sharesAverage Trading Volume11,769 sharesToday's Volume Vs. Average1% Short Selling Algernon Pharmaceuticals? Sign up to receive the latest short interest report for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGNPF Short Interest Over TimeAGNPF Days to Cover Over TimeAGNPF Percentage of Float Shorted Over Time Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Algernon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20244,200 shares $253.05 -49.4%N/A0.4 $0.06 10/15/20248,300 shares $455.67 No ChangeN/A2 $0.05 9/30/20248,300 shares $559.42 -49.7%N/A0.8 $0.07 9/15/202416,500 shares $1,341.78 -0.6%N/A3.8 $0.08 8/31/202416,600 shares $1,328.00 No ChangeN/A1.3 $0.08 8/15/202416,600 shares $1,279.86 -0.6%N/A5.7 $0.08 Get the Latest News and Ratings for AGNPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202416,700 shares $1,504.67 +4.4%N/A0.6 $0.09 7/15/202416,000 shares $1,472.00 -13.0%N/A6.2 $0.09 6/30/202418,400 shares $1,508.80 +46.0%N/A0.9 $0.08 6/15/202412,600 shares $1,249.16 -58.3%N/A1.4 $0.10 5/31/202430,200 shares $3,473.00 +33.6%N/A1.9 $0.12 5/15/202422,600 shares $2,235.59 -7.8%N/A0.6 $0.10 4/30/202424,500 shares $2,017.33 -40.5%N/A1 $0.08 4/15/202441,200 shares $2,809.84 +34.2%N/A3.1 $0.07 3/31/202430,700 shares $2,517.40 -5.0%N/A4.4 $0.08 3/15/202432,300 shares $2,684.13 +68.2%N/A1.5 $0.08 2/29/202419,200 shares $1,065.60 No ChangeN/A0.3 $0.06 1/15/202440,600 shares $2,541.56 No ChangeN/A1.2 $0.06 12/15/20234,300 shares $259.29 -34.9%N/A0.2 $0.06 11/30/20236,600 shares $421.08 No ChangeN/A0.1 $0.06 7/31/2023800 shares $112.88 +33.3%N/A0.2 $0.14 7/15/2023600 shares $102.00 -95.7%N/A0 $0.17 6/30/202314,100 shares $1,951.44 -45.8%N/A0.5 $0.14 6/15/202326,000 shares $4,420.00 -37.5%N/A0.6 $0.17 5/31/202341,600 shares $6,306.56 +47.5%N/A1.9 $0.15 5/15/202328,200 shares $5,380.56 No ChangeN/A4 $0.19 4/30/202328,200 shares $5,358.00 -14.8%N/A0.9 $0.19 4/15/202333,100 shares $6,130.12 +13.4%N/A1.3 $0.19 3/31/202329,200 shares $5,548.00 +2,333.3%N/A0.7 $0.19 3/15/20231,200 shares $477.00 +50.0%N/A0 $0.40 2/28/2023800 shares $250.00 No ChangeN/A0.2 $0.31 2/15/2023800 shares $1,200.00 No ChangeN/A0.5 $1.50 1/31/2023800 shares $1,245.28 -42.9%N/A0.2 $1.56 1/15/20231,400 shares $2,352.00 No ChangeN/A0.3 $1.68 12/30/20221,400 shares $2,287.60 -26.3%N/A0.2 $1.63 12/15/20221,900 shares $3,537.80 +18.8%N/A0.5 $1.86 11/30/20221,600 shares $2,896.00 -69.2%N/A0.3 $1.81 11/15/20225,200 shares $11,440.00 +225.0%N/A0.8 $2.20 10/31/20221,600 shares $3,200.00 -23.8%N/A0.2 $2.00 10/15/20222,100 shares $5,000.31 -46.2%N/A0.3 $2.38Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 9/30/20223,900 shares $11,817.00 -69.1%N/A0.3 $3.03 9/15/202212,600 shares $50,066.10 -28.8%N/A0.5 $3.97 8/31/202217,700 shares $72,570.00 +2,850.0%N/A1.5 $4.10 8/15/2022600 shares $1,899.60 +200.0%N/A0.2 $3.17 7/31/2022200 shares $540.00 -60.0%N/A0 $2.70 7/15/2022500 shares $1,182.50 -87.2%N/A0.3 $2.37 6/30/20223,900 shares $11,349.00 -64.9%N/A1 $2.91 6/15/202211,100 shares $48,618.00 +52.1%N/A2.1 $4.38 5/31/20227,300 shares $30,003.00 No ChangeN/A3 $4.11 3/15/2022100 shares $410.00 No ChangeN/A0 $4.10 2/28/2022100 shares $446.30 No ChangeN/A0 $4.46 1/31/2022500 shares $2,830.00 +150.0%N/A0 $5.66 1/15/2022200 shares $1,344.00 -92.0%N/A0 $6.72 12/31/20212,500 shares $8,275.00 No ChangeN/A0.2 $3.31 11/15/202115,300 shares $79,560.00 +1,175.0%N/A0 $5.20 10/29/20211,200 shares $75.60 +200.0%N/A0 $0.06 10/15/2021400 shares $25.68 -99.3%N/A0 $0.06 9/30/202160,700 shares $4,315.77 +462.0%N/A0.2 $0.07 9/15/202110,800 shares $799.20 +10,700.0%N/A0 $0.07 8/31/2021100 shares $7.75 -100.0%N/A0 $0.08 8/13/2021184,600 shares $18,460.00 +638.4%N/A0.3 $0.10 7/30/202125,000 shares $1,750.00 +101.6%N/A0 $0.07 7/15/202112,400 shares $891.56 -51.9%N/A0 $0.07 6/30/202125,800 shares $2,758.02 +15.2%N/A0 $0.11 6/15/202122,400 shares $2,757.44 -40.6%N/A0 $0.12 5/28/202137,900 shares $5,059.65 -9.1%N/A0.1 $0.13 5/14/202141,700 shares $5,358.45 +24.5%N/A0.1 $0.13 4/30/202133,500 shares $5,025.00 -49.2%N/A0 $0.15 4/15/202165,900 shares $8,507.69 +40.2%N/A0 $0.13 3/31/202147,000 shares $10,885.20 +240.6%N/A0.1 $0.23 3/15/202113,800 shares $3,265.08 -73.7%N/A0 $0.24 2/26/202152,400 shares $14,483.36 No ChangeN/A0 $0.28 1/29/202121,500 shares $4,203.25 +7.5%N/A0 $0.20 1/15/2021178,900 shares $32,508.81 +87.3%N/A0.1 $0.18 12/31/202042,100 shares $7,767.45 -76.5%N/A0 $0.18 12/15/2020178,900 shares $68,339.80 +87.3%N/A0.1 $0.38 11/30/202095,500 shares $18,145.00 +55.5%N/A0.1 $0.19 AGNPF Short Interest - Frequently Asked Questions What is Algernon Pharmaceuticals' current short interest? Short interest is the volume of Algernon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 4,200 shares of AGNPF short. Learn More on Algernon Pharmaceuticals' current short interest. Is Algernon Pharmaceuticals' short interest increasing or decreasing? Algernon Pharmaceuticals saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 4,200 shares, a decline of 49.4% from the previous total of 8,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Algernon Pharmaceuticals stock? Short selling AGNPF is an investing strategy that aims to generate trading profit from Algernon Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Algernon Pharmaceuticals? A short squeeze for Algernon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGNPF, which in turn drives the price of the stock up even further. How often is Algernon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGNPF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Interest Data 4Front Ventures Short Interest Data Allstar Health Brands Short Interest Data Alvotech Short Interest Data American Premium Mining Short Interest Data Anthera Pharmaceuticals Short Interest Data AstraZeneca Short Interest Data Atlantic Coastal Acquisition Corp. II Short Interest Data AVVAA World Health Care Products Short Interest Data Bespoke Extracts Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:AGNPF) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Algernon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Algernon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGNPF Stock Alerts